Soluventis Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $400K
Latest Deal Amount
  • Investors
  • 2

Soluventis General Information


Developer of oligonucleotide therapeutics designed to transport therapeutic nucleic acids and peptides. The company's therapeutics help in transporting the active substances from blood and immune system and reaching reliable target organs including poorly vascularized tumor tissue, enabling clinicians to reduce tumor bulges in a shorter period of time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Universitaetsstrasse 136
  • 44799 Bochum
  • Germany
+49 0234 0000000

Soluventis Timeline

Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Soluventis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 01-Jan-2019 $400K 00000 Completed Generating Revenue
2. Seed Round 01-Jan-2018 00000 00000 Completed Generating Revenue
1. Seed Round 01-Feb-2011 Completed Generating Revenue
To view Soluventis’s complete valuation and funding history, request access »

Soluventis Executive Team (4)

Name Title Board Seat Contact Info
Edvin Munk President, Managing Director & Acting Chief Executive Officer
Sören Schreiber Co-Founder, Managing Director & Chief Scientific Officer
Désirée Garten Co-Founder & Vice President of Research & Development
Michelle Zaniboni Vice President of Finance
To view Soluventis’s complete executive team members history, request access »

Soluventis Board Members (2)

Name Representing Role Since
Antonius Schuh Ph.D Self Board Member 000 0000
Stephen Zaniboni Self Board Member 000 0000
To view Soluventis’s complete board members history, request access »

Soluventis Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Global Source Ventures Venture Capital Minority 000 0000 000000 0
Mey Capital Matrix Venture Capital Minority 000 0000 000000 0
To view Soluventis’s complete investors history, request access »